Epidemiology of Multiple Congenital Anomalies Before and After Implementation of a Nationwide Prenatal Screening Program in Denmark.
EUROCAT
multiple congenital anomalies
prenatal screening
prevalence
survival
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
10
2020
accepted:
12
01
2021
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
Surveillance of congenital anomalies is important in order to detect negative influences from environment, medication, or lifestyle as early as possible. Since most teratogens are associated with a spectrum of birth defects rather than a single defect, analysis of the epidemiology of multiple congenital anomalies is important to detect an increase due to environmental or medicine exposure. The aim of the study was to describe changes in prevalence, types of anomalies, and outcome of pregnancies for fetuses and infants with multiple congenital anomalies before and after introduction of the new screening program in the County of Funen, Denmark. The study was based on data from the EUROCAT registry of the County of Funen for the period 1990 to 2014 covering 135,057 births. The registry includes information about livebirths, fetal deaths after 20 weeks of gestation and terminations of pregnancy after prenatal diagnosis of fetal anomalies. All cases with two or more major congenital anomalies in different organ systems, where the pattern of anomalies were not recognized as part of a chromosomal or genetic syndrome or a sequence were included in the study. Overall prevalence of multiple congenital anomalies was 19.7 per 10,000 pregnancies. There was no significant change in prevalence over time. The prenatal detection rate increased from 26 to 57% after introduction of the screening program (
Identifiants
pubmed: 33614552
doi: 10.3389/fped.2021.614864
pmc: PMC7893097
doi:
Types de publication
Journal Article
Langues
eng
Pagination
614864Informations de copyright
Copyright © 2021 Toxværd and Garne.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S44-50
pubmed: 21384529
Teratology. 1987 Dec;36(3):345-53
pubmed: 3424223
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S2-15
pubmed: 21384531
BMC Pregnancy Childbirth. 2018 Jun 14;18(1):231
pubmed: 29898683
Birth Defects Res A Clin Mol Teratol. 2014 Apr;100(4):270-6
pubmed: 24723551
Genet Epidemiol. 1988;5(3):183-202
pubmed: 3262553
Epidemiol Rev. 1994;16(2):335-50
pubmed: 7713183
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Am J Med Genet. 1990 Jan;35(1):121-5
pubmed: 2301461